Global Dual Orexin Receptor Antagonist Sleeping Pills Market Growth 2026-2032

October 2026 | 84 pages | ID: G2A5F9FCF478EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Dual Orexin Receptor Antagonist Sleeping Pills market size is predicted to grow from US$ 799 million in 2025 to US$ 1305 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

Dual Orexin Receptor Antagonist (DORA) sleeping pills are a class of innovative central nervous system drugs that promote sleep by blocking the activity of orexin receptors (Orexin-1R and Orexin-2R) in the hypothalamus. By inhibiting the transmission of wake-promoting signals, these agents help patients fall asleep naturally and maintain sleep without significantly affecting sleep architecture. Representative drugs include Daridorexant, Suvorexant, and Lemborexant. The upstream raw materials primarily consist of pharmaceutical-grade organic intermediates, heterocyclic compounds, and pyridine and imidazole derivatives. Core suppliers include Idorsia’s raw material production facilities in Switzerland, Sumitomo Chemical (Japan), BASF (Germany), Mitsubishi Chemical (Japan), and leading Chinese companies such as WuXi AppTec and Asymchem, together forming a globalized network for raw material and formulation supply.

Dual Orexin Receptor Antagonists (DORAs) represent a new generation of sleep-promoting medications with distinct advantages over traditional benzodiazepine, non-benzodiazepine, or melatonin receptor agonist hypnotics. By selectively blocking orexin-mediated wakefulness pathways, DORAs induce sleep in a physiologically natural manner without suppressing the central nervous system or altering normal sleep architecture. They provide restorative sleep with minimal next-day sedation, low potential for dependence or withdrawal, and favorable long-term safety. Moreover, DORAs do not significantly impair cognition, motor coordination, or memory, making them suitable for chronic insomnia patients, including those with comorbid anxiety or depression, and marking a paradigm shift in sleep medicine toward neuroregulatory mechanisms rather than sedation.

In 2024, global sales of Dual Orexin Receptor Antagonist sleeping pills reached 4,219,182 boxes, with a production capacity of 6,000,000 boxes. The average unit price was USD 159 per box, and the average corporate gross profit margin ranged between 60% and 70%.

Regional Market Structure

In the global market for Dual Orexin Receptor Antagonist sleeping drugs, North America accounts for 46%, Europe for 28%, Asia-Pacific for 21%, and other regions for 5%. North America maintains its leading position driven by a high prevalence of insomnia, mature prescription systems, and comprehensive insurance coverage. Europe demonstrates stable growth supported by regulatory relaxation and improved patient awareness, while the Asia-Pacific region—particularly China, Japan, and South Korea—is emerging as a new growth engine with faster registration and market access. Other regions, though smaller in scale, show increasing potential and diversified development momentum.

Technology Trends and Innovation Directions

Technological progress centers on molecular optimization to enhance receptor selectivity and metabolic stability, with drug design evolving toward shorter half-lives and higher efficacy-to-safety ratios to minimize residual sedation. Formulation technology is advancing toward orally disintegrating tablets, sustained-release preparations, and combination therapies to address diverse patient needs. Digitalization and artificial intelligence are increasingly applied in compound screening, clinical trial design, and personalized therapy, marking a shift in sleep medicine from traditional sedation to precision neuroregulation.

Policy and Industry Development Drivers

Rising global demand for insomnia treatment, stronger mental health policies, and innovation incentives are the key industry drivers. In Western markets, accelerated approval pathways and market exclusivity provisions support rapid commercialization of novel drugs, while in Asia, consistency evaluation and localization policies enhance generic drug competitiveness. Regulators are imposing stricter requirements on long-term safety and dependency risk, prompting companies to strengthen clinical evidence accumulation. Expansion of healthcare coverage and growing public awareness of sleep health together form the foundation for sustainable industry growth.

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “Dual Orexin Receptor Antagonist Sleeping Pills Industry Forecast” looks at past sales and reviews total world Dual Orexin Receptor Antagonist Sleeping Pills sales in 2025, providing a comprehensive analysis by region and market sector of projected Dual Orexin Receptor Antagonist Sleeping Pills sales for 2026 through 2032. With Dual Orexin Receptor Antagonist Sleeping Pills sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dual Orexin Receptor Antagonist Sleeping Pills industry.

This Insight Report provides a comprehensive analysis of the global Dual Orexin Receptor Antagonist Sleeping Pills landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dual Orexin Receptor Antagonist Sleeping Pills portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dual Orexin Receptor Antagonist Sleeping Pills market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dual Orexin Receptor Antagonist Sleeping Pills and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dual Orexin Receptor Antagonist Sleeping Pills.

This report presents a comprehensive overview, market shares, and growth opportunities of Dual Orexin Receptor Antagonist Sleeping Pills market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

  • Suvorexant
  • Lemborexant
  • Daridorexant

Segmentation by Dosage Form:

  • Tablets
  • Other

Segmentation by Research Attributes:

  • Original Drug
  • Generic Drug

Segmentation by Application:

  • Hospital and Clinic
  • Retail Pharmacies
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Merck
  • Eisal
  • Idorsia
  • Simcere Pharmaceutical
  • Nxera Pharma

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Dual Orexin Receptor Antagonist Sleeping Pills market?
  • What factors are driving Dual Orexin Receptor Antagonist Sleeping Pills market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Dual Orexin Receptor Antagonist Sleeping Pills market opportunities vary by end market size?
  • How does Dual Orexin Receptor Antagonist Sleeping Pills break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Dual Orexin Receptor Antagonist Sleeping Pills by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Dual Orexin Receptor Antagonist Sleeping Pills by Country/Region, 2021, 2025 & 2032
2.2 Dual Orexin Receptor Antagonist Sleeping Pills Segment by Type
  2.2.1 Suvorexant
  2.2.2 Lemborexant
  2.2.3 Daridorexant
  2.2.4 Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type
    2.2.4.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Type (2021-2026)
    2.2.4.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Price by Type (2021-2026)
2.3 Dual Orexin Receptor Antagonist Sleeping Pills Segment by Dosage Form
  2.3.1 Tablets
  2.3.2 Other
  2.3.3 Dual Orexin Receptor Antagonist Sleeping Pills Sales by Dosage Form
    2.3.3.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Dosage Form (2021-2026)
    2.3.3.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue and Market Share by Dosage Form (2021-2026)
    2.3.3.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Price by Dosage Form (2021-2026)
2.4 Dual Orexin Receptor Antagonist Sleeping Pills Segment by Research Attributes
  2.4.1 Original Drug
  2.4.2 Generic Drug
  2.4.3 Dual Orexin Receptor Antagonist Sleeping Pills Sales by Research Attributes
    2.4.3.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Research Attributes (2021-2026)
    2.4.3.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue and Market Share by Research Attributes (2021-2026)
    2.4.3.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Price by Research Attributes (2021-2026)
2.5 Dual Orexin Receptor Antagonist Sleeping Pills Segment by Application
  2.5.1 Hospital and Clinic
  2.5.2 Retail Pharmacies
  2.5.3 Other
  2.5.4 Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application
    2.5.4.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Market Share by Application (2021-2026)
    2.5.4.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue and Market Share by Application (2021-2026)
    2.5.4.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Breakdown Data by Company
  3.1.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Annual Sales by Company (2021-2026)
  3.1.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Company (2021-2026)
3.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Annual Revenue by Company (2021-2026)
  3.2.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Company (2021-2026)
  3.2.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Company (2021-2026)
3.3 Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Price by Company
3.4 Key Manufacturers Dual Orexin Receptor Antagonist Sleeping Pills Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Dual Orexin Receptor Antagonist Sleeping Pills Product Location Distribution
  3.4.2 Players Dual Orexin Receptor Antagonist Sleeping Pills Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DUAL OREXIN RECEPTOR ANTAGONIST SLEEPING PILLS BY GEOGRAPHIC REGION

4.1 World Historic Dual Orexin Receptor Antagonist Sleeping Pills Market Size by Geographic Region (2021-2026)
  4.1.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Dual Orexin Receptor Antagonist Sleeping Pills Market Size by Country/Region (2021-2026)
  4.2.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Annual Revenue by Country/Region (2021-2026)
4.3 Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales Growth
4.4 APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales Growth
4.5 Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales Growth
4.6 Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales Growth

5 AMERICAS

5.1 Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country
  5.1.1 Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2021-2026)
  5.1.2 Americas Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2021-2026)
5.2 Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2021-2026)
5.3 Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales by Region
  6.1.1 APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales by Region (2021-2026)
  6.1.2 APAC Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Region (2021-2026)
6.2 APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2021-2026)
6.3 APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Dual Orexin Receptor Antagonist Sleeping Pills by Country
  7.1.1 Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2021-2026)
  7.1.2 Europe Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2021-2026)
7.2 Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2021-2026)
7.3 Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills by Country
  8.1.1 Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2021-2026)
8.2 Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2021-2026)
8.3 Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dual Orexin Receptor Antagonist Sleeping Pills
10.3 Manufacturing Process Analysis of Dual Orexin Receptor Antagonist Sleeping Pills
10.4 Industry Chain Structure of Dual Orexin Receptor Antagonist Sleeping Pills

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Dual Orexin Receptor Antagonist Sleeping Pills Distributors
11.3 Dual Orexin Receptor Antagonist Sleeping Pills Customer

12 WORLD FORECAST REVIEW FOR DUAL OREXIN RECEPTOR ANTAGONIST SLEEPING PILLS BY GEOGRAPHIC REGION

12.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Market Size Forecast by Region
  12.1.1 Global Dual Orexin Receptor Antagonist Sleeping Pills Forecast by Region (2027-2032)
  12.1.2 Global Dual Orexin Receptor Antagonist Sleeping Pills Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Dual Orexin Receptor Antagonist Sleeping Pills Forecast by Type (2027-2032)
12.7 Global Dual Orexin Receptor Antagonist Sleeping Pills Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolios and Specifications
  13.1.3 Merck Dual Orexin Receptor Antagonist Sleeping Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 Eisal
  13.2.1 Eisal Company Information
  13.2.2 Eisal Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolios and Specifications
  13.2.3 Eisal Dual Orexin Receptor Antagonist Sleeping Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Eisal Main Business Overview
  13.2.5 Eisal Latest Developments
13.3 Idorsia
  13.3.1 Idorsia Company Information
  13.3.2 Idorsia Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolios and Specifications
  13.3.3 Idorsia Dual Orexin Receptor Antagonist Sleeping Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Idorsia Main Business Overview
  13.3.5 Idorsia Latest Developments
13.4 Simcere Pharmaceutical
  13.4.1 Simcere Pharmaceutical Company Information
  13.4.2 Simcere Pharmaceutical Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolios and Specifications
  13.4.3 Simcere Pharmaceutical Dual Orexin Receptor Antagonist Sleeping Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Simcere Pharmaceutical Main Business Overview
  13.4.5 Simcere Pharmaceutical Latest Developments
13.5 Nxera Pharma
  13.5.1 Nxera Pharma Company Information
  13.5.2 Nxera Pharma Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolios and Specifications
  13.5.3 Nxera Pharma Dual Orexin Receptor Antagonist Sleeping Pills Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Nxera Pharma Main Business Overview
  13.5.5 Nxera Pharma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Dual Orexin Receptor Antagonist Sleeping Pills Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Dual Orexin Receptor Antagonist Sleeping Pills Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Suvorexant
Table 4. Major Players of Lemborexant
Table 5. Major Players of Daridorexant
Table 6. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2021-2026) & (K Units)
Table 7. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Type (2021-2026)
Table 8. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Type (2021-2026) & ($ million)
Table 9. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Type (2021-2026)
Table 10. Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Tablets
Table 12. Major Players of Other
Table 13. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Dosage Form (2021-2026) & (K Units)
Table 14. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Dosage Form (2021-2026)
Table 15. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Dosage Form (2021-2026) & ($ million)
Table 16. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Dosage Form (2021-2026)
Table 17. Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 18. Major Players of Original Drug
Table 19. Major Players of Generic Drug
Table 20. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Research Attributes (2021-2026) & (K Units)
Table 21. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Research Attributes (2021-2026)
Table 22. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Research Attributes (2021-2026) & ($ million)
Table 23. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Research Attributes (2021-2026)
Table 24. Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Price by Research Attributes (2021-2026) & (US$/Unit)
Table 25. Global Dual Orexin Receptor Antagonist Sleeping Pills Sale by Application (2021-2026) & (K Units)
Table 26. Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Market Share by Application (2021-2026)
Table 27. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Application (2021-2026) & ($ million)
Table 28. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Application (2021-2026)
Table 29. Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Company (2021-2026) & (K Units)
Table 31. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Company (2021-2026)
Table 32. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Company (2021-2026)
Table 34. Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Dual Orexin Receptor Antagonist Sleeping Pills Producing Area Distribution and Sales Area
Table 36. Players Dual Orexin Receptor Antagonist Sleeping Pills Products Offered
Table 37. Dual Orexin Receptor Antagonist Sleeping Pills Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Geographic Region (2021-2026) & (K Units)
Table 41. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share Geographic Region (2021-2026)
Table 42. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country/Region (2021-2026) & (K Units)
Table 45. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Country/Region (2021-2026)
Table 46. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2021-2026) & (K Units)
Table 49. Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Country (2021-2026)
Table 50. Americas Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2021-2026) & (K Units)
Table 52. Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application (2021-2026) & (K Units)
Table 53. APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales by Region (2021-2026) & (K Units)
Table 54. APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Region (2021-2026)
Table 55. APAC Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2021-2026) & (K Units)
Table 57. APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application (2021-2026) & (K Units)
Table 58. Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2021-2026) & (K Units)
Table 59. Europe Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2021-2026) & (K Units)
Table 61. Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application (2021-2026) & (K Units)
Table 62. Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales by Country (2021-2026) & (K Units)
Table 63. Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales by Type (2021-2026) & (K Units)
Table 65. Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales by Application (2021-2026) & (K Units)
Table 66. Key Market Drivers & Growth Opportunities of Dual Orexin Receptor Antagonist Sleeping Pills
Table 67. Key Market Challenges & Risks of Dual Orexin Receptor Antagonist Sleeping Pills
Table 68. Key Industry Trends of Dual Orexin Receptor Antagonist Sleeping Pills
Table 69. Dual Orexin Receptor Antagonist Sleeping Pills Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Dual Orexin Receptor Antagonist Sleeping Pills Distributors List
Table 72. Dual Orexin Receptor Antagonist Sleeping Pills Customer List
Table 73. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Forecast by Region (2027-2032) & (K Units)
Table 74. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Americas Dual Orexin Receptor Antagonist Sleeping Pills Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales Forecast by Region (2027-2032) & (K Units)
Table 78. APAC Dual Orexin Receptor Antagonist Sleeping Pills Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Europe Dual Orexin Receptor Antagonist Sleeping Pills Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Forecast by Type (2027-2032) & (K Units)
Table 84. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Forecast by Application (2027-2032) & (K Units)
Table 86. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Merck Basic Information, Dual Orexin Receptor Antagonist Sleeping Pills Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolios and Specifications
Table 89. Merck Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Merck Main Business
Table 91. Merck Latest Developments
Table 92. Eisal Basic Information, Dual Orexin Receptor Antagonist Sleeping Pills Manufacturing Base, Sales Area and Its Competitors
Table 93. Eisal Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolios and Specifications
Table 94. Eisal Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Eisal Main Business
Table 96. Eisal Latest Developments
Table 97. Idorsia Basic Information, Dual Orexin Receptor Antagonist Sleeping Pills Manufacturing Base, Sales Area and Its Competitors
Table 98. Idorsia Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolios and Specifications
Table 99. Idorsia Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Idorsia Main Business
Table 101. Idorsia Latest Developments
Table 102. Simcere Pharmaceutical Basic Information, Dual Orexin Receptor Antagonist Sleeping Pills Manufacturing Base, Sales Area and Its Competitors
Table 103. Simcere Pharmaceutical Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolios and Specifications
Table 104. Simcere Pharmaceutical Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Simcere Pharmaceutical Main Business
Table 106. Simcere Pharmaceutical Latest Developments
Table 107. Nxera Pharma Basic Information, Dual Orexin Receptor Antagonist Sleeping Pills Manufacturing Base, Sales Area and Its Competitors
Table 108. Nxera Pharma Dual Orexin Receptor Antagonist Sleeping Pills Product Portfolios and Specifications
Table 109. Nxera Pharma Dual Orexin Receptor Antagonist Sleeping Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Nxera Pharma Main Business
Table 111. Nxera Pharma Latest Developments

LIST OF FIGURES

Figure 1. Picture of Dual Orexin Receptor Antagonist Sleeping Pills
Figure 2. Dual Orexin Receptor Antagonist Sleeping Pills Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Dual Orexin Receptor Antagonist Sleeping Pills Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Country/Region (2025)
Figure 10. Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Suvorexant
Figure 12. Product Picture of Lemborexant
Figure 13. Product Picture of Daridorexant
Figure 14. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Type in 2026
Figure 15. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Tablets
Figure 17. Product Picture of Other
Figure 18. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Dosage Form in 2026
Figure 19. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Dosage Form (2021-2026)
Figure 20. Product Picture of Original Drug
Figure 21. Product Picture of Generic Drug
Figure 22. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Research Attributes in 2026
Figure 23. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Research Attributes (2021-2026)
Figure 24. Dual Orexin Receptor Antagonist Sleeping Pills Consumed in Hospital and Clinic
Figure 25. Global Dual Orexin Receptor Antagonist Sleeping Pills Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 26. Dual Orexin Receptor Antagonist Sleeping Pills Consumed in Retail Pharmacies
Figure 27. Global Dual Orexin Receptor Antagonist Sleeping Pills Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 28. Dual Orexin Receptor Antagonist Sleeping Pills Consumed in Other
Figure 29. Global Dual Orexin Receptor Antagonist Sleeping Pills Market: Other (2021-2026) & (K Units)
Figure 30. Global Dual Orexin Receptor Antagonist Sleeping Pills Sale Market Share by Application (2025)
Figure 31. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Application in 2026
Figure 32. Dual Orexin Receptor Antagonist Sleeping Pills Sales by Company in 2026 (K Units)
Figure 33. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Company in 2026
Figure 34. Dual Orexin Receptor Antagonist Sleeping Pills Revenue by Company in 2026 ($ millions)
Figure 35. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Company in 2026
Figure 36. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Geographic Region in 2026
Figure 38. Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales 2021-2026 (K Units)
Figure 39. Americas Dual Orexin Receptor Antagonist Sleeping Pills Revenue 2021-2026 ($ millions)
Figure 40. APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales 2021-2026 (K Units)
Figure 41. APAC Dual Orexin Receptor Antagonist Sleeping Pills Revenue 2021-2026 ($ millions)
Figure 42. Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales 2021-2026 (K Units)
Figure 43. Europe Dual Orexin Receptor Antagonist Sleeping Pills Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales 2021-2026 (K Units)
Figure 45. Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Revenue 2021-2026 ($ millions)
Figure 46. Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Country in 2026
Figure 47. Americas Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Country (2021-2026)
Figure 48. Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Type (2021-2026)
Figure 49. Americas Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Application (2021-2026)
Figure 50. United States Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Region in 2026
Figure 55. APAC Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Region (2021-2026)
Figure 56. APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Type (2021-2026)
Figure 57. APAC Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Application (2021-2026)
Figure 58. China Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 62. India Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Country in 2026
Figure 66. Europe Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share by Country (2021-2026)
Figure 67. Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Type (2021-2026)
Figure 68. Europe Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Application (2021-2026)
Figure 69. Germany Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 70. France Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share by Application (2021-2026)
Figure 77. Egypt Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Dual Orexin Receptor Antagonist Sleeping Pills Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Dual Orexin Receptor Antagonist Sleeping Pills in 2026
Figure 83. Manufacturing Process Analysis of Dual Orexin Receptor Antagonist Sleeping Pills
Figure 84. Industry Chain Structure of Dual Orexin Receptor Antagonist Sleeping Pills
Figure 85. Channels of Distribution
Figure 86. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Forecast by Region (2027-2032)
Figure 87. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Dual Orexin Receptor Antagonist Sleeping Pills Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Dual Orexin Receptor Antagonist Sleeping Pills Revenue Market Share Forecast by Application (2027-2032)